Clovis Oncology
(OTC) CLVS
Clovis Oncology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$103.70M
Net Income (TTM)
$251.91M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CLVS News
CLVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clovis Oncology
Industry
Biotechnology
Sector
Health CareEmployees
413
CEO
Patrick J. Mahaffy
Website
www.clovisoncology.comHeadquarters
Boulder, CO 80301, US
CLVS Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
1%
Return on Capital
-67%
Return on Assets
-56%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$109.93M
Operating Income
$233.25M
EBITDA
$114.35M
Operating Cash Flow
$196.06M
Capital Expenditure
$312.00K
Free Cash Flow
$196.37M
Cash & ST Invst.
$143.43M
Total Debt
$638.37M
Clovis Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$1.34M
-96.5%
Gross Profit
$5.92M
-121.1%
Gross Margin
-4.41%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
413
N/A
Net Income
$56.01M
+16.9%
EBITDA
$91.67M
-1318.9%
Quarterly Fundamentals
Net Cash
$400.25M
+11.4%
Accounts Receivable
$19.45M
-24.5%
Inventory
$11.42M
-33.9%
Long Term Debt
$455.11M
-0.4%
Short Term Debt
$3.45M
-0.7%
Return on Assets
-55.94%
N/A
Return on Invested Capital
-67.10%
N/A
Free Cash Flow
$40.70M
+11.8%
Operating Cash Flow
$40.61M
+11.8%